Overview

AZD7687 Multiple Ascending Dose Study

Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD7687 following multiple ascending dose administrations in in overweight to obese but otherwise healthy male subjects
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca